Oncology

2023 Dates TBD – The European Society for Medical Oncology (ESMO) and Total Health Conferencing partnered to expand access in the US to the latest developments in the management of cancer from ESMO with three hybrid medical education programs. View conference details

Join this collaborative forum to navigate the complex landscape of oncology care with leading experts from across the state. This event will explore the latest clinical advancements, the intricacies of new and existing treatments, and the influence of national policies on state-level initiatives. Register today to secure your spot and stay ahead in the rapidly evolving world of oncology care.

This collaboration is with the mission and vision to bring together all relevant hematology and oncology personnel from Alabama, Mississippi, and beyond at a single venue to learn, teach, and collaborate.

A two-day event packed with leading speakers, research and cutting-edge presentations on the latest advancements in cancer immunotherapy, with dedicated sessions on different therapeutic modalities as well as case studies on innovative preclinical and translational tools.

Join the CAR-TCR Summit Europe to connect with those trailblazing the next wave of CAR and TCR based approaches from preclinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to make CAR and TCR therapies better, and faster. Take advantage of cutting-edge innovation from global biopharma leaders in cell armouring, combination approaches and multiplexing gene engineering to improve cell durability and trafficking across allogeneic and solid tumor indications, and leave understanding the technical strategies to build automated, closed-system manufacturing processes to ensure vein to vein time is less than a week. Promising data-driven case studies outlining next generation product design, clinical trial set-up and manufacturing processes, this meeting is your go-to to comprehensively assess the emerging improvements of CAR and TCR based therapies across all emerging cell types including T, NK, macrophage, gamma delta T and iPSC.

Over the past 10 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI’s IO Summit provides.

The world’s premier event in malignant and non-malignant hematology.

The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm
ways to advance orphan drug development and improve access to life-saving therapies.

The Oncology Site Solutions Summit is focused on delivering best practices and connections for operational excellence and success for Oncology research sites and our partners throughout the clinical research enterprise.

The annual meeting brings together more than 40,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies and ongoing controversies in the field.